英文别名 |
Pomalidomide-PEG5-CO2H;3-[2-[2-[2-[2-[2-[[2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]eth;Pomalidomide 4'-PEG5-acid;1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12,15-pentaoxaoctadecan-18-oic acid;Crosslinker−E3 Ligase ligand conjugate;Partial PROTAC;Template for synthesis of targeted protein degrader;SY309955;3-[2-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidyl)-1,3-dioxo-isoindolin-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid;Pomalidomide-NH-CO-PEG6-butyl iodide;CS-0138168;MFCD32173790;Pomalidomide-PEG5-COOH;3-[2-[2-[2-[2-[2-[[2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid;E83723;MS-30243;2139348-63-1;Pomalidomide-PEG5-Acid;HY-131647;Pomalidomide-PEG5-C2-acid;1-[[2-(2,6-Dioxo-3-piperidyl)-1,3-dioxo-4-isoindolinyl]amino]-3,6,9,12,15-pentaoxaoctadecan-18-oic Acid;Pomalidomide-2-2-2-2-2-2-6-I;SCHEMBL20242353;Pomalidomide-PEG5-CH2CH2COOH;DA-56981 |